Neogen Chemicals Limited

BSE:542665 Stock Report

Market Cap: ₹59.6b

Neogen Chemicals Management

Management criteria checks 4/4

Neogen Chemicals' CEO is Harin Kanani, appointed in Oct 2025, has a tenure of less than a year. total yearly compensation is ₹15.00M, comprised of 90.7% salary and 9.3% bonuses, including company stock and options. directly owns 17.02% of the company’s shares, worth ₹10.14B. The average tenure of the management team and the board of directors is 2.3 years and 8.5 years respectively.

Key information

Harin Kanani

Chief executive officer

₹15.0m

Total compensation

CEO salary percentage90.67%
CEO tenureless than a year
CEO ownership17.0%
Management average tenure2.3yrs
Board average tenure8.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Harin Kanani's remuneration changed compared to Neogen Chemicals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

₹288m

Dec 31 2025n/an/a

₹197m

Sep 30 2025n/an/a

₹261m

Jun 30 2025n/an/a

₹336m

Mar 31 2025₹15m₹14m

₹348m

Dec 31 2024n/an/a

₹494m

Sep 30 2024n/an/a

₹404m

Jun 30 2024n/an/a

₹374m

Mar 31 2024₹20m₹13m

₹357m

Dec 31 2023n/an/a

₹330m

Sep 30 2023n/an/a

₹467m

Jun 30 2023n/an/a

₹486m

Mar 31 2023₹8m₹8m

₹500m

Dec 31 2022n/an/a

₹513m

Sep 30 2022n/an/a

₹471m

Jun 30 2022n/an/a

₹484m

Mar 31 2022₹6m₹6m

₹446m

Dec 31 2021n/an/a

₹383m

Sep 30 2021n/an/a

₹364m

Jun 30 2021n/an/a

₹326m

Mar 31 2021₹5m₹5m

₹313m

Dec 31 2020n/an/a

₹293m

Sep 30 2020n/an/a

₹290m

Jun 30 2020n/an/a

₹293m

Mar 31 2020₹5m₹5m

₹287m

Compensation vs Market: Harin's total compensation ($USD155.51K) is below average for companies of similar size in the Indian market ($USD403.17K).

Compensation vs Earnings: Harin's compensation has been consistent with company performance over the past year.

CEO

Harin Kanani (50 yo)

less than a year
Tenure
₹15,000,000
Compensation

Dr. Harin Haridas Kanani, Ph D serves as the Managing Director of Neogen Chemicals Limited since July 22, 2017 and serves as its Executive Director since July 15, 2013. Dr. Kanani served as Joint Managing...

Leadership Team

NamePositionTenureCompensationOwnership
Harin Kanani
MD & Executive Directorless than a year₹15.00m17.02%
₹ 10.1b
Shyamsunder Upadhyay
Director of Operations & Whole Time Directorno data₹12.50m0.00029%
₹ 172.8k
Gopikrishnan Sarathy
Chief Financial Officer1.8yrsno datano data
Unnati Kanani
Company Secretary & Compliance Officer6.7yrs₹690.56kno data
Navin Jha
Senior General Manager of Marketingno datano datano data
Kirit Chauhan
Senior Vice President of Human Resourceno datano datano data
B. Pant
Senior Vice President of Business Development2.8yrsno datano data
2.3yrs
Average Tenure
50yo
Average Age

Experienced Management: 542665's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Harin Kanani
MD & Executive Director13yrs₹15.00m17.02%
₹ 10.1b
Shyamsunder Upadhyay
Director of Operations & Whole Time Director11yrs₹12.50m0.00029%
₹ 172.8k
Anurag Surana
Non-Executive Non-Independent Chairman9.2yrsno data0.82%
₹ 489.5m
Haridas Kanani
Chairman Emeritus37.3yrs₹15.00m6.41%
₹ 3.8b
Ranjan Malik
Independent Non-Executive Director7.8yrs₹400.00kno data
Avi Sabavala
Independent Non-Executive Woman Director7.8yrs₹500.00kno data
Rajeshkumar Shah
Independent Director1.9yrs₹200.00k0.0011%
₹ 655.3k
Manoj Pati
Independent Director1.8yrs₹200.00kno data
8.5yrs
Average Tenure
67yo
Average Age

Experienced Board: 542665's board of directors are considered experienced (8.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/19 02:28
End of Day Share Price 2026/07/17 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neogen Chemicals Limited is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null null360 ONE Capital Market Private Limited
null nullAsian Markets Securities Private Limited
Arun PrasathAvendus Spark